NGS-Based Monitoring and Diagnostic Test is based on the NGS, aiming for the monitoring and diagnostic test. Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an entire human genome can be sequenced within a single day.

The global market for NGS-Based Monitoring and Diagnostic Test was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for NGS-Based Monitoring and Diagnostic Test, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of NGS-Based Monitoring and Diagnostic Test by region & country, by Type, and by Application.

The NGS-Based Monitoring and Diagnostic Test market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NGS-Based Monitoring and Diagnostic Test.

Market Segmentation

Scope of NGS-Based Monitoring and Diagnostic Test - Market Report

Report Metric	Details
Report Name	NGS-Based Monitoring and Diagnostic Test - Market
CAGR	5%
Segment by Type:	Commercial Assays/Tests Laboratory Developed Tests Direct to Consumer Test Pre-Commercial Tests
Segment by Application	Out-Patient Clinics/General Practitioners Diagnostic Centers Hospitals Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Agilent Technologies, Inc., Ancestry.com LLC, ArcherDX, Inc., Beijing Genomics Institute (BGI), Cancer Genetics, Inc., CENTOGENE AG, F. Hoffmann-La Roche Ltd, GenePath Dx, Illumina, Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Siemens Healthineers, Inc., Thermo Fisher Scientific Inc., HTG Molecular Diagnostics, Inc., Vela Diagnostics Pte. Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of NGS-Based Monitoring and Diagnostic Test manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of NGS-Based Monitoring and Diagnostic Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of NGS-Based Monitoring and Diagnostic Test in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the NGS-Based Monitoring and Diagnostic Test - Market report?

Ans: The main players in the NGS-Based Monitoring and Diagnostic Test - Market are Agilent Technologies, Inc., Ancestry.com LLC, ArcherDX, Inc., Beijing Genomics Institute (BGI), Cancer Genetics, Inc., CENTOGENE AG, F. Hoffmann-La Roche Ltd, GenePath Dx, Illumina, Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Siemens Healthineers, Inc., Thermo Fisher Scientific Inc., HTG Molecular Diagnostics, Inc., Vela Diagnostics Pte. Ltd.

What are the Application segmentation covered in the NGS-Based Monitoring and Diagnostic Test - Market report?

Ans: The Applications covered in the NGS-Based Monitoring and Diagnostic Test - Market report are Out-Patient Clinics/General Practitioners, Diagnostic Centers, Hospitals, Others

What are the Type segmentation covered in the NGS-Based Monitoring and Diagnostic Test - Market report?

Ans: The Types covered in the NGS-Based Monitoring and Diagnostic Test - Market report are Commercial Assays/Tests, Laboratory Developed Tests, Direct to Consumer Test, Pre-Commercial Tests

1 Market Overview

1.1 NGS-Based Monitoring and Diagnostic Test Product Introduction

1.2 Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast

1.3 NGS-Based Monitoring and Diagnostic Test Market Trends & Drivers

1.3.1 NGS-Based Monitoring and Diagnostic Test Industry Trends

1.3.2 NGS-Based Monitoring and Diagnostic Test Market Drivers & Opportunity

1.3.3 NGS-Based Monitoring and Diagnostic Test Market Challenges

1.3.4 NGS-Based Monitoring and Diagnostic Test Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global NGS-Based Monitoring and Diagnostic Test Players Revenue Ranking (2023)

2.2 Global NGS-Based Monitoring and Diagnostic Test Revenue by Company (2019-2024)

2.3 Key Companies NGS-Based Monitoring and Diagnostic Test Manufacturing Base Distribution and Headquarters

2.4 Key Companies NGS-Based Monitoring and Diagnostic Test Product Offered

2.5 Key Companies Time to Begin Mass Production of NGS-Based Monitoring and Diagnostic Test

2.6 NGS-Based Monitoring and Diagnostic Test Market Competitive Analysis

2.6.1 NGS-Based Monitoring and Diagnostic Test Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by NGS-Based Monitoring and Diagnostic Test Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-Based Monitoring and Diagnostic Test as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Commercial Assays/Tests

3.1.2 Laboratory Developed Tests

3.1.3 Direct to Consumer Test

3.1.4 Pre-Commercial Tests

3.2 Global NGS-Based Monitoring and Diagnostic Test Sales Value by Type

3.2.1 Global NGS-Based Monitoring and Diagnostic Test Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global NGS-Based Monitoring and Diagnostic Test Sales Value, by Type (2019-2030)

3.2.3 Global NGS-Based Monitoring and Diagnostic Test Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Out-Patient Clinics/General Practitioners

4.1.2 Diagnostic Centers

4.1.3 Hospitals

4.1.4 Others

4.2 Global NGS-Based Monitoring and Diagnostic Test Sales Value by Application

4.2.1 Global NGS-Based Monitoring and Diagnostic Test Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global NGS-Based Monitoring and Diagnostic Test Sales Value, by Application (2019-2030)

4.2.3 Global NGS-Based Monitoring and Diagnostic Test Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global NGS-Based Monitoring and Diagnostic Test Sales Value by Region

5.1.1 Global NGS-Based Monitoring and Diagnostic Test Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global NGS-Based Monitoring and Diagnostic Test Sales Value by Region (2019-2024)

5.1.3 Global NGS-Based Monitoring and Diagnostic Test Sales Value by Region (2025-2030)

5.1.4 Global NGS-Based Monitoring and Diagnostic Test Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America NGS-Based Monitoring and Diagnostic Test Sales Value, 2019-2030

5.2.2 North America NGS-Based Monitoring and Diagnostic Test Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe NGS-Based Monitoring and Diagnostic Test Sales Value, 2019-2030

5.3.2 Europe NGS-Based Monitoring and Diagnostic Test Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific NGS-Based Monitoring and Diagnostic Test Sales Value, 2019-2030

5.4.2 Asia Pacific NGS-Based Monitoring and Diagnostic Test Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America NGS-Based Monitoring and Diagnostic Test Sales Value, 2019-2030

5.5.2 South America NGS-Based Monitoring and Diagnostic Test Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Sales Value, 2019-2030

5.6.2 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions NGS-Based Monitoring and Diagnostic Test Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions NGS-Based Monitoring and Diagnostic Test Sales Value

6.3 United States

6.3.1 United States NGS-Based Monitoring and Diagnostic Test Sales Value, 2019-2030

6.3.2 United States NGS-Based Monitoring and Diagnostic Test Sales Value by Type (%), 2023 VS 2030

6.3.3 United States NGS-Based Monitoring and Diagnostic Test Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe NGS-Based Monitoring and Diagnostic Test Sales Value, 2019-2030

6.4.2 Europe NGS-Based Monitoring and Diagnostic Test Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe NGS-Based Monitoring and Diagnostic Test Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China NGS-Based Monitoring and Diagnostic Test Sales Value, 2019-2030

6.5.2 China NGS-Based Monitoring and Diagnostic Test Sales Value by Type (%), 2023 VS 2030

6.5.3 China NGS-Based Monitoring and Diagnostic Test Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan NGS-Based Monitoring and Diagnostic Test Sales Value, 2019-2030

6.6.2 Japan NGS-Based Monitoring and Diagnostic Test Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan NGS-Based Monitoring and Diagnostic Test Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea NGS-Based Monitoring and Diagnostic Test Sales Value, 2019-2030

6.7.2 South Korea NGS-Based Monitoring and Diagnostic Test Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea NGS-Based Monitoring and Diagnostic Test Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia NGS-Based Monitoring and Diagnostic Test Sales Value, 2019-2030

6.8.2 Southeast Asia NGS-Based Monitoring and Diagnostic Test Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia NGS-Based Monitoring and Diagnostic Test Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India NGS-Based Monitoring and Diagnostic Test Sales Value, 2019-2030

6.9.2 India NGS-Based Monitoring and Diagnostic Test Sales Value by Type (%), 2023 VS 2030

6.9.3 India NGS-Based Monitoring and Diagnostic Test Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Agilent Technologies, Inc.

7.1.1 Agilent Technologies, Inc. Profile

7.1.2 Agilent Technologies, Inc. Main Business

7.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.1.4 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.1.5 Agilent Technologies, Inc. Recent Developments

7.2 Ancestry.com LLC

7.2.1 Ancestry.com LLC Profile

7.2.2 Ancestry.com LLC Main Business

7.2.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.2.4 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.2.5 Ancestry.com LLC Recent Developments

7.3 ArcherDX, Inc.

7.3.1 ArcherDX, Inc. Profile

7.3.2 ArcherDX, Inc. Main Business

7.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.3.4 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.3.5 Beijing Genomics Institute (BGI) Recent Developments

7.4 Beijing Genomics Institute (BGI)

7.4.1 Beijing Genomics Institute (BGI) Profile

7.4.2 Beijing Genomics Institute (BGI) Main Business

7.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.4.4 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.4.5 Beijing Genomics Institute (BGI) Recent Developments

7.5 Cancer Genetics, Inc.

7.5.1 Cancer Genetics, Inc. Profile

7.5.2 Cancer Genetics, Inc. Main Business

7.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.5.4 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.5.5 Cancer Genetics, Inc. Recent Developments

7.6 CENTOGENE AG

7.6.1 CENTOGENE AG Profile

7.6.2 CENTOGENE AG Main Business

7.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.6.4 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.6.5 CENTOGENE AG Recent Developments

7.7 F. Hoffmann-La Roche Ltd

7.7.1 F. Hoffmann-La Roche Ltd Profile

7.7.2 F. Hoffmann-La Roche Ltd Main Business

7.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.7.4 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.7.5 F. Hoffmann-La Roche Ltd Recent Developments

7.8 GenePath Dx

7.8.1 GenePath Dx Profile

7.8.2 GenePath Dx Main Business

7.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.8.4 GenePath Dx NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.8.5 GenePath Dx Recent Developments

7.9 Illumina, Inc.

7.9.1 Illumina, Inc. Profile

7.9.2 Illumina, Inc. Main Business

7.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.9.4 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.9.5 Illumina, Inc. Recent Developments

7.10 Laboratory Corporation of America Holdings

7.10.1 Laboratory Corporation of America Holdings Profile

7.10.2 Laboratory Corporation of America Holdings Main Business

7.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.10.4 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.10.5 Laboratory Corporation of America Holdings Recent Developments

7.11 Myriad Genetics, Inc.

7.11.1 Myriad Genetics, Inc. Profile

7.11.2 Myriad Genetics, Inc. Main Business

7.11.3 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.11.4 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.11.5 Myriad Genetics, Inc. Recent Developments

7.12 QIAGEN N.V.

7.12.1 QIAGEN N.V. Profile

7.12.2 QIAGEN N.V. Main Business

7.12.3 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.12.4 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.12.5 QIAGEN N.V. Recent Developments

7.13 Quest Diagnostics Incorporated

7.13.1 Quest Diagnostics Incorporated Profile

7.13.2 Quest Diagnostics Incorporated Main Business

7.13.3 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.13.4 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.13.5 Quest Diagnostics Incorporated Recent Developments

7.14 Siemens Healthineers, Inc.

7.14.1 Siemens Healthineers, Inc. Profile

7.14.2 Siemens Healthineers, Inc. Main Business

7.14.3 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.14.4 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.14.5 Siemens Healthineers, Inc. Recent Developments

7.15 Thermo Fisher Scientific Inc.

7.15.1 Thermo Fisher Scientific Inc. Profile

7.15.2 Thermo Fisher Scientific Inc. Main Business

7.15.3 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.15.4 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.15.5 Thermo Fisher Scientific Inc. Recent Developments

7.16 HTG Molecular Diagnostics, Inc.

7.16.1 HTG Molecular Diagnostics, Inc. Profile

7.16.2 HTG Molecular Diagnostics, Inc. Main Business

7.16.3 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.16.4 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.16.5 HTG Molecular Diagnostics, Inc. Recent Developments

7.17 Vela Diagnostics Pte. Ltd.

7.17.1 Vela Diagnostics Pte. Ltd. Profile

7.17.2 Vela Diagnostics Pte. Ltd. Main Business

7.17.3 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

7.17.4 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Revenue (US$ Million) & (2019-2024)

7.17.5 Vela Diagnostics Pte. Ltd. Recent Developments

8 Industry Chain Analysis

8.1 NGS-Based Monitoring and Diagnostic Test Industrial Chain

8.2 NGS-Based Monitoring and Diagnostic Test Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 NGS-Based Monitoring and Diagnostic Test Sales Model

8.5.2 Sales Channel

8.5.3 NGS-Based Monitoring and Diagnostic Test Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Agilent Technologies Inc

Ancestry.com LLC

Archerdx

Beijing Genomics Institute (BGI)

Cancer Genetics Inc.

CENTOGENE

F Hoffmann La Roche Ltd

GenePath Dx

Illumina Inc

Laboratory Corporation of America Holdings

Myriad Genetics Inc

QIAGEN N V

Quest Diagnostics Incorporated

Siemens Healthineers Inc

Thermo Fisher Scientific Inc

HTG Molecular Diagnostics, Inc.

Vela Diagnostics Pte. Ltd.

List of Tables

Table 1. NGS-Based Monitoring and Diagnostic Test Market Trends

Table 2. NGS-Based Monitoring and Diagnostic Test Market Drivers & Opportunity

Table 3. NGS-Based Monitoring and Diagnostic Test Market Challenges

Table 4. NGS-Based Monitoring and Diagnostic Test Market Restraints

Table 5. Global NGS-Based Monitoring and Diagnostic Test Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Company (2019-2024)

Table 7. Key Companies NGS-Based Monitoring and Diagnostic Test Manufacturing Base Distribution and Headquarters

Table 8. Key Companies NGS-Based Monitoring and Diagnostic Test Product Type

Table 9. Key Companies Time to Begin Mass Production of NGS-Based Monitoring and Diagnostic Test

Table 10. Global NGS-Based Monitoring and Diagnostic Test Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-Based Monitoring and Diagnostic Test as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global NGS-Based Monitoring and Diagnostic Test Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global NGS-Based Monitoring and Diagnostic Test Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global NGS-Based Monitoring and Diagnostic Test Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global NGS-Based Monitoring and Diagnostic Test Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global NGS-Based Monitoring and Diagnostic Test Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global NGS-Based Monitoring and Diagnostic Test Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global NGS-Based Monitoring and Diagnostic Test Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global NGS-Based Monitoring and Diagnostic Test Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global NGS-Based Monitoring and Diagnostic Test Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global NGS-Based Monitoring and Diagnostic Test Sales Value by Region (2019-2024) & (%)

Table 27. Global NGS-Based Monitoring and Diagnostic Test Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions NGS-Based Monitoring and Diagnostic Test Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions NGS-Based Monitoring and Diagnostic Test Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions NGS-Based Monitoring and Diagnostic Test Sales Value, (2025-2030) & (US$ Million)

Table 31. Agilent Technologies, Inc. Basic Information List

Table 32. Agilent Technologies, Inc. Description and Business Overview

Table 33. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 34. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of Agilent Technologies, Inc. (2019-2024)

Table 35. Agilent Technologies, Inc. Recent Developments

Table 36. Ancestry.com LLC Basic Information List

Table 37. Ancestry.com LLC Description and Business Overview

Table 38. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 39. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of Ancestry.com LLC (2019-2024)

Table 40. Ancestry.com LLC Recent Developments

Table 41. ArcherDX, Inc. Basic Information List

Table 42. ArcherDX, Inc. Description and Business Overview

Table 43. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 44. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of ArcherDX, Inc. (2019-2024)

Table 45. ArcherDX, Inc. Recent Developments

Table 46. Beijing Genomics Institute (BGI) Basic Information List

Table 47. Beijing Genomics Institute (BGI) Description and Business Overview

Table 48. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 49. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of Beijing Genomics Institute (BGI) (2019-2024)

Table 50. Beijing Genomics Institute (BGI) Recent Developments

Table 51. Cancer Genetics, Inc. Basic Information List

Table 52. Cancer Genetics, Inc. Description and Business Overview

Table 53. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 54. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of Cancer Genetics, Inc. (2019-2024)

Table 55. Cancer Genetics, Inc. Recent Developments

Table 56. CENTOGENE AG Basic Information List

Table 57. CENTOGENE AG Description and Business Overview

Table 58. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 59. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of CENTOGENE AG (2019-2024)

Table 60. CENTOGENE AG Recent Developments

Table 61. F. Hoffmann-La Roche Ltd Basic Information List

Table 62. F. Hoffmann-La Roche Ltd Description and Business Overview

Table 63. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 64. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of F. Hoffmann-La Roche Ltd (2019-2024)

Table 65. F. Hoffmann-La Roche Ltd Recent Developments

Table 66. GenePath Dx Basic Information List

Table 67. GenePath Dx Description and Business Overview

Table 68. GenePath Dx NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 69. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of GenePath Dx (2019-2024)

Table 70. GenePath Dx Recent Developments

Table 71. Illumina, Inc. Basic Information List

Table 72. Illumina, Inc. Description and Business Overview

Table 73. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 74. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of Illumina, Inc. (2019-2024)

Table 75. Illumina, Inc. Recent Developments

Table 76. Laboratory Corporation of America Holdings Basic Information List

Table 77. Laboratory Corporation of America Holdings Description and Business Overview

Table 78. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 79. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of Laboratory Corporation of America Holdings (2019-2024)

Table 80. Laboratory Corporation of America Holdings Recent Developments

Table 81. Myriad Genetics, Inc. Basic Information List

Table 82. Myriad Genetics, Inc. Description and Business Overview

Table 83. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 84. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of Myriad Genetics, Inc. (2019-2024)

Table 85. Myriad Genetics, Inc. Recent Developments

Table 86. QIAGEN N.V. Basic Information List

Table 87. QIAGEN N.V. Description and Business Overview

Table 88. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 89. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of QIAGEN N.V. (2019-2024)

Table 90. QIAGEN N.V. Recent Developments

Table 91. Quest Diagnostics Incorporated Basic Information List

Table 92. Quest Diagnostics Incorporated Description and Business Overview

Table 93. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 94. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of Quest Diagnostics Incorporated (2019-2024)

Table 95. Quest Diagnostics Incorporated Recent Developments

Table 96. Siemens Healthineers, Inc. Basic Information List

Table 97. Siemens Healthineers, Inc. Description and Business Overview

Table 98. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 99. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of Siemens Healthineers, Inc. (2019-2024)

Table 100. Siemens Healthineers, Inc. Recent Developments

Table 101. Thermo Fisher Scientific Inc. Basic Information List

Table 102. Thermo Fisher Scientific Inc. Description and Business Overview

Table 103. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 104. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of Thermo Fisher Scientific Inc. (2019-2024)

Table 105. Thermo Fisher Scientific Inc. Recent Developments

Table 106. HTG Molecular Diagnostics, Inc. Basic Information List

Table 107. HTG Molecular Diagnostics, Inc. Description and Business Overview

Table 108. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 109. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of HTG Molecular Diagnostics, Inc. (2019-2024)

Table 110. HTG Molecular Diagnostics, Inc. Recent Developments

Table 111. Vela Diagnostics Pte. Ltd. Basic Information List

Table 112. Vela Diagnostics Pte. Ltd. Description and Business Overview

Table 113. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Products, Services and Solutions

Table 114. Revenue (US$ Million) in NGS-Based Monitoring and Diagnostic Test Business of Vela Diagnostics Pte. Ltd. (2019-2024)

Table 115. Vela Diagnostics Pte. Ltd. Recent Developments

Table 116. Key Raw Materials Lists

Table 117. Raw Materials Key Suppliers Lists

Table 118. NGS-Based Monitoring and Diagnostic Test Downstream Customers

Table 119. NGS-Based Monitoring and Diagnostic Test Distributors List

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

Table 123. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. NGS-Based Monitoring and Diagnostic Test Product Picture

Figure 2. Global NGS-Based Monitoring and Diagnostic Test Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global NGS-Based Monitoring and Diagnostic Test Sales Value (2019-2030) & (US$ Million)

Figure 4. NGS-Based Monitoring and Diagnostic Test Report Years Considered

Figure 5. Global NGS-Based Monitoring and Diagnostic Test Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by NGS-Based Monitoring and Diagnostic Test Revenue in 2023

Figure 7. NGS-Based Monitoring and Diagnostic Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Commercial Assays/Tests Picture

Figure 9. Laboratory Developed Tests Picture

Figure 10. Direct to Consumer Test Picture

Figure 11. Pre-Commercial Tests Picture

Figure 12. Global NGS-Based Monitoring and Diagnostic Test Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global NGS-Based Monitoring and Diagnostic Test Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Out-Patient Clinics/General Practitioners

Figure 15. Product Picture of Diagnostic Centers

Figure 16. Product Picture of Hospitals

Figure 17. Product Picture of Others

Figure 18. Global NGS-Based Monitoring and Diagnostic Test Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global NGS-Based Monitoring and Diagnostic Test Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America NGS-Based Monitoring and Diagnostic Test Sales Value (2019-2030) & (US$ Million)

Figure 21. North America NGS-Based Monitoring and Diagnostic Test Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe NGS-Based Monitoring and Diagnostic Test Sales Value (2019-2030) & (US$ Million)

Figure 23. Europe NGS-Based Monitoring and Diagnostic Test Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific NGS-Based Monitoring and Diagnostic Test Sales Value (2019-2030) & (US$ Million)

Figure 25. Asia Pacific NGS-Based Monitoring and Diagnostic Test Sales Value by Country (%), 2023 VS 2030

Figure 26. South America NGS-Based Monitoring and Diagnostic Test Sales Value (2019-2030) & (US$ Million)

Figure 27. South America NGS-Based Monitoring and Diagnostic Test Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Sales Value (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions NGS-Based Monitoring and Diagnostic Test Sales Value (%), (2019-2030)

Figure 31. United States NGS-Based Monitoring and Diagnostic Test Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States NGS-Based Monitoring and Diagnostic Test Sales Value by Type (%), 2023 VS 2030

Figure 33. United States NGS-Based Monitoring and Diagnostic Test Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe NGS-Based Monitoring and Diagnostic Test Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe NGS-Based Monitoring and Diagnostic Test Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe NGS-Based Monitoring and Diagnostic Test Sales Value by Application (%), 2023 VS 2030

Figure 37. China NGS-Based Monitoring and Diagnostic Test Sales Value, (2019-2030) & (US$ Million)

Figure 38. China NGS-Based Monitoring and Diagnostic Test Sales Value by Type (%), 2023 VS 2030

Figure 39. China NGS-Based Monitoring and Diagnostic Test Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan NGS-Based Monitoring and Diagnostic Test Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan NGS-Based Monitoring and Diagnostic Test Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan NGS-Based Monitoring and Diagnostic Test Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea NGS-Based Monitoring and Diagnostic Test Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea NGS-Based Monitoring and Diagnostic Test Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea NGS-Based Monitoring and Diagnostic Test Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia NGS-Based Monitoring and Diagnostic Test Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia NGS-Based Monitoring and Diagnostic Test Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia NGS-Based Monitoring and Diagnostic Test Sales Value by Application (%), 2023 VS 2030

Figure 49. India NGS-Based Monitoring and Diagnostic Test Sales Value, (2019-2030) & (US$ Million)

Figure 50. India NGS-Based Monitoring and Diagnostic Test Sales Value by Type (%), 2023 VS 2030

Figure 51. India NGS-Based Monitoring and Diagnostic Test Sales Value by Application (%), 2023 VS 2030

Figure 52. NGS-Based Monitoring and Diagnostic Test Industrial Chain

Figure 53. NGS-Based Monitoring and Diagnostic Test Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions